FURUYA Shuichi
No ORCID on file
· 418 papers in corpus
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2001
The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic ca…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…